Jardiance Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Condition:   End Stage Renal Disease on Dialysis Interventions:   Drug: Empagliflozin 25 mg vs Placebo;   Drug: Empagliflozin 10 MG Sponsors:   Yale University;   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2023 Category: Research Source Type: clinical trials